Navigation Links
Niels Bohr Institute gets top researcher from Harvard
Date:1/10/2012

A grant of 38 million Danish Kroner from the VILLUM FOUNDATION paves the way for a brand new professorship at the Niels Bohr Institute for the world's leading researcher in the field of quantum physics, Professor Charles Marcus.

After a lot of spadework to find and attract a physicist of international standing the Niels Bohr Institute can now look forward to receiving a grant of 38 million DKK from the VILLUM FOUNDATION. The grant has allowed for the creation of a permanent position for the world-leading researcher in the field of quantum electronics, Professor Charles Marcus. Charles Marcus is coming from a position as a professor at one of the world's leading universities, Harvard University in the USA.

Entirely new funding possibilities in Denmark

The grant represents the first instance in Denmark where a private foundation is financing the creation of a permanent professorship known in the English-speaking university world as 'endowed chairs'.

"This is a great new opportunity that the VILLUM FOUNDATION is demonstrating. This generous donation from the foundation represents a new way to attract exceptionally talented researchers to Danish universities by guaranteeing researchers permanent and attractive employment conditions," says Professor John Renner Hansen, Head of the Niels Bohr Institute.

When the institute contacted Professor Marcus to offer him the new Villum Kann Rasmussen Professorship with the huge grant in hand, he was not difficult to persuade. A few years ago, Professor Marcus had a very successful guest stay at the Niels Bohr Institute, so he was very familiar with the institute and its international research environment. The ability to hire a researcher of Professor Marcus' international rank paved the way in late 2011 to attract funds for a new centre from the Danish National Research Foundation, the 'Center for Quantum Devices', under the leadership of Professor Marcus.

"I
'/>"/>

Contact: Gertie Skaarup
skaarup@nbi.dk
(45) 35-32-53-20
University of Copenhagen
Source:Eurekalert  

Page: 1 2 3

Related biology technology :

1. Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development
2. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
3. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
4. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
5. Michael A. Marletta Takes Office as New President of Scripps Research Institute
6. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
7. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
8. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
9. New England Research Institutes (NERI) Announces Additional $45M NIH Grant to Support the Pediatric Heart Network
10. Metabolomx Awarded $1.14 Million SBIR Grant from National Cancer Institute for Breath Analysis Test of Lung Cancer
11. SAIC Awarded Contract by National Institute of Allergy and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Niels Bohr Institute gets top researcher from Harvard
(Date:5/20/2013)... 2013 , Collaboration with ... (ARS) in treatment of mastitis , ... Trials to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will ... Research Service (ARS) to develop and trial products targeting ...
(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...
(Date:5/20/2013)... With bed bugs' presence come problems in various ... need to be eliminated, one must make sure that the ... And so to help bed bug sufferers get that done, ... bed bugs without using harmful pesticides. In it, the ... Bed Bug Bully. , According to My Cleaning Products, contrary ...
(Date:5/20/2013)... May 20, 2013 Rhythm announced today the ... RM-131, the company,s novel ghrelin agonist for the treatment ... trial demonstrated that RM-131 significantly accelerates early gastric emptying ... diabetic patients with diabetic gastroparesis. The findings were presented ... Orlando and recently published in ...
Breaking Biology Technology:Phosphagenics Signs Research Agreement with the Agricultural Research Service 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3
... by 45.7%, Profit Attributable to Shareholders ... 14 /Xinhua-PRNewswire/ -- Fufeng Group Limited,("Fufeng" or "the ... corn-based biochemical products in China, today announces,its interim ... 2008., During the period under review, driven ...
... Aug. 14 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... the,discovery, development and commercialization of novel drugs in ... today,announced its financial results for the second quarter ... ), The net loss for the three ...
... Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a provider ... second quarter and first six months ended,June 30, 2008. ... and,distribution capacity provided by the Company,s new First Aid ... flagship product, MEDIHONEY(R). For,the second quarter in 2008, the ...
Cached Biology Technology:Fufeng Announces 2008 Interim Results With Strong Sign of Recovery 2Fufeng Announces 2008 Interim Results With Strong Sign of Recovery 3Advanced Life Sciences Announces Second Quarter 2008 Financial Results 2Advanced Life Sciences Announces Second Quarter 2008 Financial Results 3Advanced Life Sciences Announces Second Quarter 2008 Financial Results 4Advanced Life Sciences Announces Second Quarter 2008 Financial Results 5Advanced Life Sciences Announces Second Quarter 2008 Financial Results 6Advanced Life Sciences Announces Second Quarter 2008 Financial Results 7Advanced Life Sciences Announces Second Quarter 2008 Financial Results 8Advanced Life Sciences Announces Second Quarter 2008 Financial Results 9Advanced Life Sciences Announces Second Quarter 2008 Financial Results 10Derma Sciences Reports Second Quarter 2008 Results 2Derma Sciences Reports Second Quarter 2008 Results 3Derma Sciences Reports Second Quarter 2008 Results 4Derma Sciences Reports Second Quarter 2008 Results 5
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
(Date:5/17/2013)... residents of all ages will celebrate the science ... on our daily lives during the inaugural Atlanta ... and educators from local museums, corporations, K-12 schools ... 40 different events for children and adults at ... http://atlantasciencefestival.org . , The annual Atlanta Science ...
(Date:5/17/2013)... Efficient and Sustainable Global Logistics Operations) is aiming to ... efficiency of intermodal loading systems and the boosting of ... European organisations with experience in the logistics sector and ... 17,000,000 and a duration of three and a half ... the semantic components and ontologies shared by the users, ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2New logistics services that will cut energy consumption and CO2 emissions 2
... New research suggests a higher-protein, lower-carbohydrate energy-restricted diet has ... fat and increasing lean muscle, particularly when the proteins ... the September issue of the Journal of Nutrition, ... otherwise healthy, premenopausal women. Each consumed either low, ...
... Lithuania, Aug. 29, 2011 Neurotechnology ... technologies, today announced the availability of SentiSight 3.0 ... recognition. This latest version adds shape-based recognition and offers ... SentiSight 2.1. It also includes enhanced tracking of fast ...
... which can stop the formation of long protein strands, ... kidney dialysis patients has been identified by researchers at ... to new methods to identify drugs to prevent, treat ... amyloid fibrils play a part, including Alzheimer,s, Parkinson,s and ...
Cached Biology News:Foods rich in protein, dairy products help dieters preserve muscle and lose belly fat: study 2SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 2SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 3SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 4Research offers new way to target shape-shifting proteins 2
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
WTAP Antibody...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
...
Biology Products: